Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome

Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome

Abstract Background Treatment with high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (aHSCT) is an intensive treatment option for patients with severe forms of systemic sclerosis (SSc). Even though associated with a high treatment related mortality, the results in...

Full description

Bibliographic Details
Main Authors: Ann-Christin Pecher, Reinhild Klein, Ina Koetter, Marieke Wagner, Wichard Vogel, Stefan Wirths, Claudia Lengerke, Joerg Christoph Henes
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Arthritis Research & Therapy
Subjects:
Systemic sclerosis
Autoimmunity
Autologous stem cell transplantation
Online Access:https://doi.org/10.1186/s13075-024-03300-1

Internet

https://doi.org/10.1186/s13075-024-03300-1

Similar Items